MENU
ALKS
AS OF
Nov 20, 04:59 PM (EDT)
Price
$28.20
Change
-$0.49 (-1.71%)
Capitalization
4.74B
84 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ALKS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alkermes (ALKS) Ownership - Who owns Alkermes?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
4.74B
P/E Ratio
14.28
Total Cash
1.11B
Projected Growth
N/A
Total Debt
71.6M
Revenue
1.52B
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash/Share
6.73
Total Debt/Equity
27.09
Revenue/Share
9.06 USD as % of share price

Fundamentals

ALKS
Capitalization
4.74B
P/E Ratio
14.28
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash
1.11B
Total Cash/Share
6.73
Total Debt
71.6M
Total Debt/Equity
27.09
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.06%
Revenue
1.52B
ROE
N/A
Book Value
1.73B
P/B Ratio
2.73
Cash Flow
N/A
Earnings
2.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.81M
Current Ratio
3.67
Current Revenue Per Employee
218991.67
Dividends Per Share - Security
N/A
EBITDA
436M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.91
Revenue To Assets
15.11
Shares Held By Institutions
11.5B
Shares Outstanding - Current
165M
Total Liabilities
596M
Total Volume MTD
N/A
Value
-1
Gain YTD
-0.209
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALKS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALKS showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ALKS
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com